These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8397765)

  • 1. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Trends Pharmacol Sci; 1993 May; 14(5):143-8. PubMed ID: 8212308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
    Cobbold SP; Martin G; Waldmann H
    Eur J Immunol; 1990 Dec; 20(12):2747-55. PubMed ID: 1980112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is it possible to zero the immune system? Co-stimulatory blockade: experimental studies to achieve transplantation tolerance].
    Aasvang EK; Egfjord M
    Ugeskr Laeger; 2003 Apr; 165(15):1562-5. PubMed ID: 12715660
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation for transplantation tolerance.
    Metcalfe S
    Eye (Lond); 1995; 9 ( Pt 2)():192-6. PubMed ID: 7556717
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do monoclonal antibodies induce tolerance? A role for infectious tolerance?
    Waldmann H; Cobbold S
    Annu Rev Immunol; 1998; 16():619-44. PubMed ID: 9597144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of dominant tolerance using monoclonal antibodies.
    Agua-Doce A; Graça L
    Methods Mol Biol; 2007; 380():405-29. PubMed ID: 17876109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Immunol Today; 1993 Jun; 14(6):322-6. PubMed ID: 8104411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of anti-CD4 antibodies.
    Olive D; Mawas C
    Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.
    Chatenoud L
    Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
    Chen Z; Cobbold S; Metcalfe S; Waldmann H
    Eur J Immunol; 1992 Mar; 22(3):805-10. PubMed ID: 1547823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.